Route of exposure All exposed cases (symptomatic or not) Symptomatic cases Frequency () of symptomatic cases related to all exposed cases LLP TLL p LLP TLL p LLP TLL p n n n n Oral including :                             Oral alone 6,162 81.5 5,818 84.7 <10-3 3,890 77.0 2,352 75.8 <10-3 63.1 40.4 .   Oral associated to   other routes* 325 4.3 252 3.7 217 4.3 88 2.8 66.8 34.9 . Cutaneous alone 49 0.6 72 1.0 30 0.6 46 1.5 61.2 63.9   Respiratory 0 0 22 0.3 0 0 18 0.6 . 81.8 . Ocular including                       Ocular alone 761 10.1 556 8.1 680 13.5 483 15.6 89.4 86.9 . Ocular associated to other routes† 244 3.2 140 2.0 217 4.3 112 3.6 88.9 80.0 . Others                         Anecdotic routes‡ 21 0.3 11 0.2 15 0.3 4 0.1 71.4 36.4 . Total 7,562 100 6,871 100   5,049 100 3,103 100   66.8 45.2 <10-3

* oral + cutaneous + cutaneous + respiratory; † ocular + cutaneous,  ocular + respiratory, ocular; +cutaneous + respiratory; ‡ auricular, rectal, genital, sting

Table 4: Distribution of exposed and symptomatic cases depending on the route of exposure: LLP versus TTL.